GNPX - Genprex, Inc.
0.28
-0.012 -4.429%
Share volume: 945,253
Last Updated: 05-07-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.13%
PREVIOUS CLOSE
CHG
CHG%
$0.29
-0.01
-0.04%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | |
|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 05-15-2024 | 08-09-2024 | 11-13-2024 | |
| Total revenue | 0.000 | -620.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | -620.000 | 0.000 | |
| inf% | 100.00% | |||
| Operating expenses | 5.994 M | 6.516 M | 4.322 M | |
| Selling general and admin | 2.720 M | 4.849 M | 1.566 M | |
| Research and development | 3.274 M | 1.667 M | 2.756 M | |
| Total expenses | 5.997 M | 6.518 M | 4.323 M | |
| 8.70% | -33.67% | |||
| Operating income | -5.997 M | -6.518 M | -4.323 M | |
| Ebit | -5.997 M | -6.518 M | -4.324 M | |
| Pretax income | -5.969 M | -6.495 M | -4.316 M | |
| 8.82% | -33.55% | |||
| Income tax | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | |
| Net income | -5.969 M | -6.496 M | -4.316 M | |
| -8.83% | 33.56% |
